Zoetis Inc (ZTS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Zoetis Inc   (NYSE: ZTS)
 

Zoetis Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Zoetis Inc 's inventory turnover ratio sequentially decreased to 1.08 in the second quarter 2026, unsurprisingly, as the Zoetis Inc markets continue to deteriorate, and ZTS's faces growing challenges to bring down its inventories. Zoetis Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 338 days, from 335 days, in the Mar 31 2026 quarter.

Within Healthcare sector 304 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1803, from total ranking in the first quarter 2026 at 1955.

ZTS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zoetis Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZTS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 5.54 % 7.82 % 5.38 % 2.03 % -0.53 %
Y / Y Cost of Sales Growth 3.7 % 3.05 % 0.71 % -2.57 % -2.84 %
Inventory Turnover Ratio (TTM) 1.08 1.09 1.1 1.11 1.12
ZTS's Total Ranking # 1803 # 1955 # 1875 # 1869 # 1885
Average inventory processing period 337 336 332 328 324
Seq. Inventory Growth 0.94 % 4.94 % -1.42 % 1.07 % 3.13 %
Seq. Cost of Sales Growth 4.99 % -9.97 % 4.25 % 5.24 % 4.34 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 87
Healthcare Sector # 305
Overall Market # 1803

Inventory Turnover Ratio Statistics
High Average Low
1.46 1.2 0.96
(Sep 30 2019)   (Sep 30 2023)



ZTS Company Profile >> Back to ZTS Efficiency Comparisons >> Compare ZTS Inventory Turnover Ratio to its Competitors

Financial Statements
Zoetis Inc 's Inventories $ 2,574 Millions Visit ZTS's Balance sheet
Zoetis Inc 's Cost of Revenues TTM $ 2,709 Millions Visit ZTS's Income Statement
What are ZTS's Sales? Visit ZTS's Sales by Segment

Other Inventory Turnover Ratios
Zoetis Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZTS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZTS's Competitors
Inventory Turnover Ratio for ZTS's Suppliers
Inventory Turnover Ratio for ZTS's Customers

You may also want to know
ZTS's Sales Growth Rates ZTS's Pe Price to earnings ratio ZTS's Receivables Turnover Ratio ZTS's Stock Quote
ZTS's Net Income Growth Rates ZTS's Ps Price to Sales ratio ZTS's Sales per Employee ZTS's Asset Turnover Ratio
ZTS's Net Margin ZTS's Pb Price to Book ratio ZTS's Financial Strength Ratios ZTS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions
IMPACT BIOMEDICAL INC.  2.46 $ 0.414  Millions$ 0  Millions
Quidelortho Corp  2.45 $ 1,481.500  Millions$ 605  Millions
Pro dex Inc   2.43 $ 53.213  Millions$ 22  Millions
Angiodynamics Inc   2.43 $ 142.834  Millions$ 59  Millions
Journey Medical Corp  2.42 $ 23.556  Millions$ 10  Millions
Aquestive Therapeutics Inc   2.42 $ 17.828  Millions$ 7  Millions
Viatris Inc   2.41 $ 9,604.200  Millions$ 3,993  Millions
Cannapharmarx Inc   2.37 $ 2.483  Millions$ 1  Millions
Fortress Biotech Inc   2.34 $ 22.768  Millions$ 10  Millions
Scientific Industries Inc   2.33 $ 4.057  Millions$ 2  Millions
Insight Molecular Diagnostics Inc   2.31 $ 0.868  Millions$ 0  Millions
Tela Bio Inc   2.30 $ 26.348  Millions$ 11  Millions
Sanara Medtech Inc   2.29 $ 7.981  Millions$ 3  Millions
China Pharma Holdings Inc  2.25 $ 3.450  Millions$ 2  Millions
Beta Bionics Inc   2.23 $ 50.111  Millions$ 22  Millions
Medtronic Plc  2.21 $ 13,136.000  Millions$ 5,950  Millions
Embecta Corp   2.19 $ 418.400  Millions$ 191  Millions
Avita Medical Inc   2.18 $ 13.950  Millions$ 6  Millions
Johnson and Johnson  2.17 $ 31,428.000  Millions$ 14,516  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.15 $ 14.508  Millions$ 7  Millions
Anika Therapeutics Inc   2.14 $ 46.366  Millions$ 22  Millions

Date modified: 2026-09-06T17:41:25+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.